Nicergoline (Sermion) is an ergot derivative used primarily to treat senile dementia and other disorders which are known to have a vascular origin. It is known to decrease vascular resistance and increase arterial blood flow within the brain, thus improving the utilization of oxygen and glucose uptake by brain cells.
Nicergoline increases blood flow in the vessels of the upper and lower extremities, especially in case of violation of blood flow, caused functional arteriopathy. Clinical trials have shown high efficiency of Sermion at blood flow in the vessels of the upper and lower extremities and cerebrovascular disorders failure.
Reception of Sermion at therapeutic doses usually has no effect on blood pressure. In patients with hypertension the supplement may cause a gradual reduction in blood pressure.
Country of origin: USA